Search Results - Siitari-Mattila, Mari

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Gender‐neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III)

    Gender‐neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III) by Lehtinen, Matti, Luostarinen, Tapio, Vänskä, Simopekka, Söderlund‐Strand, Anna, Eriksson, Tiina, Natunen, Kari, Apter, Dan, Baussano, Iacopo, Harjula, Katja, Hokkanen, Mari, Kuortti, Marjo, Palmroth, Johanna, Petäjä, Tiina, Pukkala, Eero, Rekonen, Sirpa, Siitari‐Mattila, Mari, Surcel, Heljä‐Marja, Tuomivaara, Leena, Paavonen, Jorma, Nieminen, Pekka, Dillner, Joakim, Dubin, Gary, Garnett, Geoff

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Impact of gender‐neutral or girls‐only vaccination against human papillomavirus—Results of a community‐randomized clinical trial (I)

    Impact of gender‐neutral or girls‐only vaccination against human papillomavirus—Results of a community‐randomized clinical trial (I) by Lehtinen, Matti, Söderlund‐Strand, Anna, Vänskä, Simopekka, Luostarinen, Tapio, Eriksson, Tiina, Natunen, Kari, Apter, Dan, Baussano, Iacopo, Harjula, Katja, Hokkanen, Mari, Kuortti, Marjo, Palmroth, Johanna, Petäjä, Tiina, Pukkala, Eero, Rekonen, Sirpa, Siitari‐Mattila, Mari, Surcel, Heljä‐Marja, Tuomivaara, Leena, Paavonen, Jorma, Dillner, Joakim, Dubin, Gary, Garnett, Geoffrey

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

    Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years by Petäjä, Tiina, M.D, Keränen, Heli, M.D, Karppa, Tiina, M.D, Kawa, Anna, M.D, Lantela, Sirkku, M.D, Siitari-Mattila, Mari, M.D, Levänen, Helena, M.D, Tocklin, Tuomas, M.D, Godeaux, Olivier, M.D, Lehtinen, Matti, M.D., Ph.D, Dubin, Gary, M.D

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials

    Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials... by Lehtinen, Matti, Lagheden, Camilla, Luostarinen, Tapio, Eriksson, Tiina, Apter, Dan, Harjula, Katja, Kuortti, Marjo, Natunen, Kari, Palmroth, Johanna, Petäjä, Tiina, Pukkala, Eero, Siitari-Mattila, Mari, Struyf, Frank, Nieminen, Pekka, Paavonen, Jorma, Dubin, Gary, Dillner, Joakim

    Published in BMJ open
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing

    Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing by LEHTINEN, Matti, APTER, Dan, PALMROTH, Johanna, PETÄJÄ, Tiina, REKONEN, Sirpa, SALMIVESI, Susanna, SIITARI-MATTILA, Mari, SVARTSJÖ, Sofia, TUOMIVAARA, Leena, VILKKI, Marjo, PUKKALA, Eero, PAAVONEN, Jorma, DUBIN, Gary, KOSUNEN, Elise, ISAKSSON, Rita, KORPIVAARA, Eeva-Leena, KYHÄ-ÖSTERLUND, Laura, LUNNAS, Terhi, LUOSTARINEN, Tapio, NIEMI, Lubov

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: